Minireviews
Copyright ©The Author(s) 2022.
World J Gastroenterol. Apr 7, 2022; 28(13): 1304-1314
Published online Apr 7, 2022. doi: 10.3748/wjg.v28.i13.1304
Table 2 Summary of published data on appendiceal neuroendocrine tumor recurrence and survival
Author (Yr)
n
Recurrence rate
Specific disease survival rate
Reported follow-up
Tsikitis et al[38], 2012982-95.6%5-yr rate
Volante et al[17], 2013138-97.1%86.5 mo (1 - 267)
Mosquera et al[39], 2017418-95.7%5-yr rate
Sarchekeh et al[40], 2017118-97.5%10-yr rate
Pawa et al[41], 2017215099.05%10-yr rate
Alexandraki et al[32], 20201362.2%100%10-yr rate
Brighi et al[5], 20204350%98.5%Median follow-up not provided, but at least 20% longer than 10 yr
Alabraba et al[1], 20211021%99%6.2 yr (0.8-27.8)
Holmager et al[28], 20213350%100%66 mo (1-250)